Showing results (1291-1300 of 1,370) with videos related to
Sort By:
Pageof 137
World Neurosurgery|March 3, 2012
A multicenter, single-blind, prospective randomized trial to evaluate the safety of a polyethylene glycol hydrogel (Duraseal Dural Sealant System) as a dural sealant in cranial surgeryJoshua W Osbun, Richard G Ellenbogen, Randall M Chesnut, et al.Nature|October 6, 2017
A hybrid type Ia supernova with an early flash triggered by helium-shell detonationJi-An Jiang, Mamoru Doi, Keiichi Maeda, et al.Journal of the American Medical Informatics Association : JAMIA|December 28, 2018
Enrichment sampling for a multi-site patient survey using electronic health records and census dataNathaniel D Mercaldo, Kyle B Brothers, David S Carrell, et al.The New England Journal of Medicine|August 31, 2016
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa InhibitorsStuart J Connolly, Truman J Milling, John W Eikelboom, et al.Molecular Cell|November 6, 2020
Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression ProgramKathryn T Bieging-Rolett, Alyssa M Kaiser, David W Morgens, et al.BMC Medical Genomics|January 7, 2021
Association between triglycerides, known risk SNVs and conserved rare variation in SLC25A40 in a multi-ancestry cohortElisabeth A Rosenthal, David R Crosslin, Adam S Gordon, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 14, 2023
Trans-ethnic genomic informed risk assessment for Alzheimer's disease: An International Hundred K+ Cohorts Consortium studyPatrick M Sleiman, Hui-Qi Qu, John J Connolly, et al.The Lancet. Neurology|January 25, 2025
Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trialAshkan Shoamanesh, Thalia S Field, Shelagh B Coutts, et al.The Journal of Pharmacology and Experimental Therapeutics|December 11, 2019
Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase InhibitorRyan M Wyatt, Ian Fraser, Natalie Welty, et al.Scientific Reports|June 21, 2017
A genome-wide association study of anorexia nervosa suggests a risk locus implicated in dysregulated leptin signalingDong Li, Xiao Chang, John J Connolly, et al.Pageof 137